Benzinga | Feb 25, 2021 04:25PM EST

Aerie Pharmaceuticals Q4 EPS $(0.79) Misses $(0.73) Estimate, Sales $24.68M Beat $22.36M Estimate

Aerie Pharmaceuticals (NASDAQ:AERI) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.73) by 8.22 percent. This is a 17.71 percent increase over losses of $(0.96) per share from the same period last year. The company reported quarterly sales of $24.68 million which beat the analyst consensus estimate of $22.36 million by 10.39 percent. This is a 0.11 percent increase over sales of $24.66 million the same period last year.